Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 31, 2003
[A case of renal cell carcinoma with lymph node metastasis keeping remission for five years by adjuvant immunotherapy with ubenimex]Osamu Sugano, Akinori Muto, Masanori Kato, et al.Protein Expression and Purification|October 18, 2005
A novel "reverse screening" to identify refolding additives for activin-ADaisuke Ejima, Kunio Ono, Kouhei Tsumoto, et al.Hinyokika Kiyo. Acta Urologica Japonica|October 17, 2006
[Small cell carcinoma of the prostate: a case report]Mitsuharu Sasaki, Takashi Kobayashi, Kunio Ono, et al.Hinyokika Kiyo. Acta Urologica Japonica|September 16, 2008
[Examination of prostate biopsy among Japanese with less than 4.0 ng/ml prostate specific antigen--usefulness of free/total PSA ratio]Masaaki Tsukigi, Ken-Ichi Suzuki, Kenzi Numahata, et al.International Journal of Clinical Oncology|April 30, 2003
Complete regression of bone metastases on super bone scan, by low-dose cisplatin, UFT, diethylstilbestrol diphosphate, and dexamethasone in a patient with hormone-refractory prostate cancerSenji Hoshi, Chikara Ohyama, Shigeru Hagisawa, et al.The Journal of Biological Chemistry|September 11, 2002
Crystal structure of microbial transglutaminase from Streptoverticillium mobaraenseTatsuki Kashiwagi, Kei-Ichi Yokoyama, Kohki Ishikawa, et al.Molecular and Clinical Oncology|September 1, 2017
Treatment sequence in castration-resistant prostate cancer: A retrospective study in the new anti-androgen eraSenji Hoshi, Kenji Numahata, Kunio Ono, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|January 4, 2007
Case of carcinosarcoma of urinary bladder obtained a pathologically complete response by neoadjuvant chemoradiotherapySenji Hoshi, Mituharu Sasaki, Akinori Muto, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 31, 2002
[Low-dose cisplatin and UFT for hormone refractory prostate cancer]Senji Hoshi, Chikara Ohyama, Shynichi Namiki, et al.International Journal of Clinical Oncology|April 27, 2004
Gemcitabine plus carboplatin; and gemcitabine, docetaxel, and carboplatin combined chemotherapy regimens in patients with metastatic urothelial carcinoma previously treated with a platinum-based regimen: preliminary reportSenji Hoshi, Chikara Ohyama, Kunio Ono, et al.Pageof 2